New Pyrazine Conjugates: Synthesis, Computational Studies, and Antiviral Properties against SARS-CoV-2
- Israa A. Seliem,
- Adel S. Girgis,
- Yassmin Moatasim,
- Ahmed Kandeil,
- Ahmed Mostafa,
- Mohamed A. Ali
- Augusta University,
- Zagazig University,
- National Research Center,
- ,
- ,
Open access
Abstract
Currently, limited therapeutic options are available for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We have developed a set of pyrazine-based small molecules. A series of pyrazine conjugates was synthesized by microwave-assisted click chemistry and benzotriazole chemistry. All the synthesized conjugates were screened against the SAR-CoV-2 virus and their cytotoxicity was determined. Computational studies were carried out to validate the biological data. Some of the pyrazine-triazole conjugates (5 d–g) and (S)-N-(1-(benzo[d]thiazol-2-yl)-2-phenylethyl)pyrazine-2-carboxamide 12 i show significant potency against SARS-CoV-2 among the synthesized conjugates. The selectivity index (SI) of potent conjugates indicates significant efficacy compared to the reference drug (Favipiravir).
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 3418-3427 (10 pages)Journal (Volume, Issue Number)
ChemMedChem (Volume 16, Issue 22)Publication milestones
- Published - 11/19/2021
Publication status
ISSN
1860-7179Publication IDs
- Scopus: 85114306669
- PubMed: 34352160
- ORCID: /0000-0003-3668-104X/work/105170395
